Sortilin is dispensable for secondary injury processes following traumatic brain injury in mice

dc.contributor.authorStaib-Lasarzik, Irina
dc.contributor.authorGölz, Christina
dc.contributor.authorBobkiewiecz, Wieslawa
dc.contributor.authorSomnuke, Pawit
dc.contributor.authorSebastiani, Anne
dc.contributor.authorThal, Serge C.
dc.contributor.authorSchäfer, Michael K. E.
dc.date.accessioned2024-12-20T06:40:31Z
dc.date.available2024-12-20T06:40:31Z
dc.date.issued2024
dc.description.abstractTraumatic brain injury (TBI) is characterized by complex secondary injury processes involving the p75 neurotrophin receptor (p75NTR), which has been proposed as a possible therapeutic target. However, the pathogenic role of the p75NTR co-receptor sortilin in TBI has not been investigated. In this study, we examined whether sortilin contributes to acute and early processes of secondary injury using a murine controlled cortical impact (CCI) model of TBI. Initial expression analysis showed a down-regulation of sortilin mRNA levels 1 and 5 day post injury (dpi) and a reduced expression of sortilin protein 1 dpi. Next, a total of 40 SortilinΔExon14 loss-of-function mouse mutants (Sort1−/−) and wild-type (Sort1+/+) littermate mice were subjected to CCI and examined at 1 and 5 dpi. Neither sensorimotor deficits or brain lesion size nor CCI-induced cell death or calcium-dependent excitotoxicity as evaluated by TUNEL staining or Western blot analysis of alpha II spectrin breakdown products were different between Sort1en_GB
dc.identifier.doihttp://doi.org/10.25358/openscience-11167
dc.identifier.urihttps://openscience.ub.uni-mainz.de/handle/20.500.12030/11188
dc.language.isoengde
dc.rightsCC-BY-4.0*
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/*
dc.subject.ddc610 Medizinde_DE
dc.subject.ddc610 Medical sciencesen_GB
dc.titleSortilin is dispensable for secondary injury processes following traumatic brain injury in miceen_GB
dc.typeZeitschriftenaufsatzde
jgu.journal.issue15de
jgu.journal.titleHeliyonde
jgu.journal.volume10de
jgu.organisation.departmentFB 04 Medizinde
jgu.organisation.nameJohannes Gutenberg-Universität Mainz
jgu.organisation.number2700
jgu.organisation.placeMainz
jgu.organisation.rorhttps://ror.org/023b0x485
jgu.pages.alternativee35198de
jgu.publisher.doi10.1016/j.heliyon.2024.e35198de
jgu.publisher.issn2405-8440de
jgu.publisher.nameElsevierde
jgu.publisher.placeLondonde
jgu.publisher.year2024
jgu.rights.accessrightsopenAccess
jgu.subject.ddccode610de
jgu.subject.dfgLebenswissenschaftende
jgu.type.contenttypeScientific articlede
jgu.type.dinitypeArticleen_GB
jgu.type.resourceTextde
jgu.type.versionPublished versionde

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
sortilin_is_dispensable_for_s-20241220073816815.pdf
Size:
6.1 MB
Format:
Adobe Portable Document Format
Description:

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
3.57 KB
Format:
Item-specific license agreed upon to submission
Description:

Collections